4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
4.2.1.1
AGEING POPULATION & CHRONIC-CARE DEMAND
4.2.1.2
RISE OF MINIMALLY INVASIVE AND CATHETER-BASED PROCEDURES
4.2.1.3
STRINGENT REGULATORY BURDEN (EU MDR)
4.2.1.4
PROCUREMENT COST PRESSURE IN PUBLIC HEALTHCARE
4.2.3.1
NEARSHORING & LOCALIZED MANUFACTURING
4.2.3.2
SUSTAINABLE & SPECIALTY-MATERIAL INNOVATIONS
4.2.4.1
SUPPLY-CHAIN VOLATILITY & GEOPOLITICAL SOURCING RISKS
4.2.4.2
WORKFORCE & CAPACITY CONSTRAINTS IN EU MANUFACTURING
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER'S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN HEALTHCARE AND MEDICAL INDUSTRY
5.5.1
AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION (2024)
5.5.2
AVERAGE SELLING PRICE TREND, BY REGION (2022-2024)
5.6.1
IMPORT SCENARIO (HS CODE 3917)
5.6.2
EXPORT SCENARIO (HS CODE 3917)
5.7
KEY CONFERENCE & EVENTS IN 2025-2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.11
IMPACT OF 2025 US TARIFF - EUROPE MEDICAL TUBING MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.11.4
IMPACT ON COUNTRY/REGION*
5.11.5
IMPACT ON END-USE INDUSTRIES
*(MARKET CONSUMPTION IMPACT, TRADE BALANCE ADJUSTMENTS, PRICING ANALYSIS, COMPANIES IMPACTED, AND COMPANIES’ STRATEGIES)
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1.1
MICRO EXTRUSION TECHNOLOGIES
6.1.2
SMART & SENSOR-EMBEDDED TUBING
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
NANOTECHNOLOGY FOR COATING
6.3
ADJACENT TECHNOLOGIES
6.3.1
ADVANCED IMAGING TECHNOLOGY
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON EUROPE MEDICAL TUBING MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES FOLLOWED BY MANUFACTURERS/OEMS IN EUROPE MEDICAL TUBING MARKET
6.7.3
CASE STUDIES RELATED TO AI IMPLEMENTATION IN EUROPE MEDICAL TUBING MARKET
6.7.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENT'S READINESS TO ADOPT GENERATIVE AI IN EUROPE MEDICAL TUBING MARKET
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.2
DECISION-MAKING PROCESS
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.5
UNMET NEEDS OF VARIOUS END-USE INDUSTRIES
9
EUROPE MEDICAL TUBING MARKET, BY MATERIAL
Market Size, Volume & Forecast – USD Million
COMPARATIVE ASSESSMENT OF KEY EUROPE MEDICAL TUBING MATERIALS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS SUPPLIER COMPANIES
Market Size, Volume & Forecast – USD Million
10
EUROPE MEDICAL TUBING MARKET, BY APPLICATION
Market Size, Volume & Forecast – USD Million
APPLICATION-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH APPLICATION
10.2
BULK DISPOSABLE TUBING
10.3
CATHETERS & CANNULAS
10.4
DRUG DELIVERY SYSTEM
11
EUROPE MEDICAL TUBING MARKET, BY STRUCTURE
Market Size, Volume & Forecast – USD Million
STRUCTURE-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING EUROPE MEDICAL TUBING ADOPTION
11.5
TAPERED OR BUMP TUBING
12
EUROPE MEDICAL TUBING MARKET, BY REGION
Market Size, Volume & Forecast – USD Million
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY COUNTRIES
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
16.2
KEY PLAYERS' STRATEGIES/RIGHT TO WIN (JANUARY 2021-DECEMBER 2025)
16.4
MARKET SHARE ANALYSIS, 2022-2024
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.6.5.1
COMPANY FOOTPRINT
16.6.5.2
COUNTRY FOOTPRINT
16.6.5.3
MATERIAL FOOTPRINT
16.6.5.4
APPLICATION FOOTPRINT
16.6.5.5
STRUCTURE FOOTPRINT
16.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
16.7.1
PROGRESSIVE COMPANIES
16.7.2
RESPONSIVE COMPANIES
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
16.8
COMPANY VALUATION AND FINANCIAL METRICS
16.9
COMPETITIVE SCENARIO
* (BUSINESS OVERVIEW, PRODUCTS MIX, RECENT DEVELOPMENTS, MNM VIEW)
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN EUROPE MEDICAL TUBING MARKET LANDSCAPE
17.1.6
TRELLEBORG MEDICAL
17.2.2
NOVOPLAST SCHLAUCHTECHNIK
17.2.4
PURESIL TECHNIFLEX
17.2.6
APT ADVANCED POLYMER TUBING GMBH
*DETAILS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
NOTE: THIS IS THE TENTATIVE LIST. WE WILL PROVIDE YOU WITH COMPANY PROFILES OF MAJOR COMPANIES IN THIS MARKET.
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
18.1.1.2
LIST OF KEY SECONDARY SOURCES
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
18.1.2.2
KEY PRIMARY PARTICIPANTS
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
18.1.2.4
KEY INDUSTRY INSIGHTS
18.2
MARKET SIZE ESTIMATION
18.2.1
BOTTOM-UP APPROACH
18.2.3
BASE NUMBER CALCULATION
18.3
MARKET FORECAST APPROACH
18.6
RESEARCH ASSUMPTIONS AND LIMITATIONS
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Europe Medical Tubing Market